KV Sinks Slowly into Oblivion

In July 9th post, I commented on KV's decision to sue FDA over the latter's non-enforcement of compounders competing with KV's Makena. I said it was only a matter of time before KV goes out of business.

KV sink .

We're one step closer now as KV filed for bankruptcy protection today. KV said the FDA's lax enforcement has prevented it from realizing its "full value" for Makena -- i.e. they couldn't charge $1500 per dose for a product that previously cost the patient $10.  So now they are left with $728 M in debts and only $237 M in assets.

Boo hoo-hoo.

Posted by Bruce Lehr Aug 6th 2012.

Comments

[bigredbruce]

Pharmalot blog reports this morning (8/13) that KV won ruling in Georgia to get State Medicaid to pay for Makena treatments
http://www.pharmalot.com/2012/08/kv-pharma-wins-a-makena-ruling-in-georgia/
Chalk one win up for KV.

[bigredbruce]

More on this story from Pharmalot blog. Now KV is also suing a couple of State's Medicaid programs
http://www.pharmalot.com/2012/08/a-bankrupt-kv-now-goes-after-some-states/